Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      EP05.01-001 - Hispanic Patients with Unresectable Stage III NSCLC under PACIFIC Protocol: Evidence of Interior Outcomes and Health Inequity

      Presenter: Andres F Cardona

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-001 - Molecular Profiling Predicts Outcomes in Patients With Resected Malignant Pleural Mesothelioma

      Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-002 - Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫)

      Presenter: Andres F Cardona

      • Abstract

      Loading...

    • +

      EP16.03-003 - Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC)

      Presenter: Andres F Cardona

      • Abstract

      Loading...

  • +

    OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines

    • 11:00 - 12:10
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      OA06.03 - Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study

      11:02 - 11:12  |  Presenter: Philip C Mack

      • Abstract

      Loading...

  • +

    P2.12 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
    • +

      P2.12-05 - Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression

      Presenter: Thomas Urban Marron

      • Abstract

      Loading...

  • +

    P2.13 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
    • +

      P2.13-01 - Low EV miR-30c Levels as Biomarker of Increased Tumor Autophagy and Chemoradiotherapy Resistance in Locally Advanced NSCLC

      Presenter: Diego de Miguel Perez

      • Abstract

      Loading...

  • +

    ES39 - Role of Novel Biomarkers and Technologies in Optimal Diagnosis and Disease Management: Focus on Liquid Biopsies And Advanced Tissue Diagnostics

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Lehar 1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      15:20 - 15:30  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      Session Moderator

      15:20 - 15:30  |  Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

    • +

      ES39.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      ES39.02 - Session Introduction

      14:31 - 14:32  |  Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

    • +

      ES39.03 - Advances and Role of CTCs for Lung Cancer Diagnosis and Treatment (Early and Advanced: NSCLC and SCLC)

      14:32 - 14:44  |  Presenter: Caroline Dive

      • Abstract

      Loading...

    • +

      ES39.04 - Optimal Use of ctDNA Analysis Lung Cancer Diagnosis, Response Assessment and Monitoring 

      14:44 - 14:56  |  Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

    • +

      ES39.05 - Biomarker Analysis of the Tumor Microenvironment and Tumor-Immune Cell Interactions Using High-Plex Spatial and Single-Cell Studies

      14:56 - 15:08  |  Presenter: Junko Tanizaki

      • Abstract

      Loading...

    • +

      ES39.06 - Advanced Tumor-Based and Circulating Diagnositics in Early Stage Disease

      15:08 - 15:20  |  Presenter: Lillian Siu

      • Abstract

      Loading...

    • +

      ES39.07 - Live Q&A

      15:20 - 15:30

      • Abstract

      Loading...